AXSM

Quote

Short

News

Articles

Message Board

Buy Recommendation Issued On AXSM By UBS

February 24, 2026 08:15:07 am

Source: KlickAnalytics

2026-02-24 08:15:07 ET

UBS analyst issues BUY recommendation for AXSM on February 24, 2026 12:56PM ET.

The previous analyst recommendation was Buy.

AXSM was trading at $174.76 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 24 - Buy, 1 - Hold recommendations .

Axsome Therapeutics Inc.

2.88% G/L:

$168 Last:

139,795 Volume:

$164.75 Open:

March 10, 2026 01:33:00 pm

March 09, 2026 04:03:48 pm

February 26, 2026 12:07:00 pm

February 25, 2026 07:00:00 am

Market Cap $9,247,694,682

Float 39,170,621

Insiders Ownership 0.27%

Institutions 150

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City New York